Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
ConforMIS Inc - SIC # 3841 - SURGICAL AND MEDICAL INSTRUMENTS AND APPARATUS
Ticker
Exchange
SIC #
Website
Latest Ticker
CFMS
Nasdaq
3841
http://www.conformis.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for ConforMIS Inc
Rock star Growth Puts Conformis (NASDAQ:CFMS) In A Position To Use Debt
- Jun 3rd, 2022 1:01 pm
Conformis Highlights New Clinical Study Findings that Knee Shapes are Highly Individualized and are Not Determined by Identifiers, Including Gender, Body Type, or Ethnicity
- May 24th, 2022 12:00 pm
Conformis, Inc. to Participate in the H.C. Wainwright Global Investment Conference
- May 10th, 2022 12:00 pm
ConforMIS (CFMS) Reports Q1 Loss, Tops Revenue Estimates
- May 4th, 2022 12:25 pm
Conformis Reports First Quarter 2022 Financial Results
- May 4th, 2022 11:00 am
SeaSpine Holdings (SPNE) Reports Q1 Loss, Tops Revenue Estimates
- May 3rd, 2022 9:45 pm
Conformis, Inc. to Release First Quarter 2022 Financial Results on May 4, 2022
- Apr 11th, 2022 8:30 pm
Conformis, Inc. Appoints Michael Fillion as Chief Operating Officer
- Apr 1st, 2022 9:00 pm
Synchrony Financial (SYF) Ties Up to Ease Orthopedic Care
- Mar 23rd, 2022 2:55 pm
Conformis Partners with Synchrony to Offer CareCredit Financial Services to Orthopedic Patients
- Mar 22nd, 2022 12:00 pm
Conformis, Inc. Appoints Denise Pedulla as Chief Legal Officer and Corporate Secretary
- Mar 14th, 2022 8:30 pm
Gary Fischetti nominated to join Conformis’ Board of Directors
- Mar 11th, 2022 1:00 pm
Conformis, Inc. Reports Fourth Quarter and Year End 2021 Financial Results
- Mar 2nd, 2022 9:05 pm
Conformis Suspends All Distribution Operations and Business Development in Russia
- Mar 2nd, 2022 1:00 pm
New Clinical Study Finds Bilateral Knee Patients Prefer Conformis’ Fully Personalized Solution Over Competitive Off-the-Shelf Implants by a Factor of Over 10 to 1
- Feb 28th, 2022 1:00 pm
Conformis iTotal® CR Knee Replacement System Awarded “7A” Performance Rating from the U.K.’s Orthopaedic Data Evaluation Panel
- Feb 24th, 2022 1:00 pm
Conformis, Inc. to Participate in Upcoming Investor Conferences
- Feb 18th, 2022 9:30 pm
New Strong Sell Stocks for February 14th
- Feb 14th, 2022 1:30 pm
Investors in Conformis (NASDAQ:CFMS) have unfortunately lost 89% over the last five years
- Feb 13th, 2022 12:28 pm
Smith+Nephew (SNN) to Acquire Orlando-Based Engage Surgical
- Jan 26th, 2022 2:10 pm
Scroll